Literature DB >> 31992421

Hypopneas with arousals: an important feature of central nervous system sympathetic activation in posttraumatic stress disorder.

Madhulika A Gupta1.   

Abstract

Entities:  

Year:  2020        PMID： 31992421      PMCID： PMC7053024          DOI： 10.5664/jcsm.8198

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  6 in total

Review 1.  Prevalence of obstructive sleep apnea in patients with posttraumatic stress disorder and its impact on adherence to continuous positive airway pressure therapy: a meta-analysis.

Authors:  Ye Zhang; Jason G Weed; Rong Ren; Xiangdong Tang; Wei Zhang
Journal:  Sleep Med       Date:  2017-05-31       Impact factor: 3.492

2.  To Die, to Sleep - to Sleep, Perchance to Dream…Without Hypertension: Dreams of the Visionary Christian Guilleminault Revisited.

Authors:  Shahrokh Javaheri; Peter C Gay
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

3.  The Association Between Obstructive Sleep Apnea Characterized by a Minimum 3 Percent Oxygen Desaturation or Arousal Hypopnea Definition and Hypertension.

Authors:  Rohit Budhiraja; Sogol Javaheri; Sairam Parthasarathy; Richard B Berry; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

4.  Effect of Varying Definitions of Hypopnea on the Calculation of the Apnea-Hypopnea Index May Depend Upon the Level of Sympathetic Activation: Results From a Patient With Posttraumatic Stress Disorder.

Authors:  Madhulika A Gupta
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 5.  Post-traumatic Stress Disorder and Cardiovascular Disease.

Authors:  Matthew M Burg; Robert Soufer
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

6.  A cause of excessive daytime sleepiness. The upper airway resistance syndrome.

Authors:  C Guilleminault; R Stoohs; A Clerk; M Cetel; P Maistros
Journal:  Chest       Date:  1993-09       Impact factor: 9.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.